A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis

NCT07298044 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloid Cardiomyopathy

Interventions

DRUG: Acoramidis

Sponsor

Bayer